Lead4Life is a public-private partnership program focused on enabling both the GMP-grade availability and the clinical applicability of the promising medical isotope lead-212. By developing scalable production processes and enabling technologies, the program supports the development of new radiopharmaceuticals and accelerates their future use in cancer care.

Around menopause women can face significant health challenges that affect their wellbeing, quality of life, and ability to work, while the societal and economic costs of inaction continue to rise. Menopause Matters brings researchers, companies, care providers and women together to create science based, technological solutions that improve health and support women in staying active at work.

The Dutch mental healthcare (GGZ) is under long-standing and growing pressure. The MentalAIde-program aims to accelerate the development and validation of AI‑driven innovations that strengthen the accessibility, efficiency, and quality of mental healthcare. The program supports and coordinates national public‑private partnerships between mental healthcare providers, SMEs, researchers, and patient organisations.

Since 2020, ORANGEHealth has been active as a partnership of all seven Dutch knowledge institutions - universities and universities of applied sciences - in the field of oral healthcare. ORANGEHealth benefits from the unique oral care system, with periodic checkups, and establishes an integrated role of the oral healthcare professional in the broader healthcare system.

Stroke is a large, societal problem: one out of four in the Netherlands will get a stroke, with huge consequences for the patient and for society. PP CONTRAST will develop innovative approaches for improving both diagnosis and treatment of patients with a stroke.

In this program, UMC Utrecht works together with Amsterdam UMC, two health funds/patient organizations and 34 professional associations, patient organizations and companies (Long Alliance Netherlands) in developing and making applicable innovative treatments for patients with hereditary lung diseases, like cystic fibrosis and primary ciliary dyskinesia.

One in two Dutch people will develop cancer, of which 20% is a rare cancer (including childhood cancers). REACT-NL, a collaboration between KWF, KiKa, and Oncode Institute, aims at improving the diagnostics and treatment of rare tumours. The program stimulates innovation within public-private partnerships, with emphasis on valorization, to enhance patient outcomes.

Repairing or replacing diseased tissues and organs with the help of the body’s self-healing capacity, that is what Regenerative Medicine is about! This program develops Regenerative Medicine solutions for patients. Academia, health foundations and companies work together to translate knowledge into therapies and get these therapies ready for the market.

RehabAI@Home is a collaborative program that combines rehabilitation and movement sciences with artificial intelligence and entrepreneurship to support higher quality and more independent rehabilitation in the home setting. RehabAI@Home uses a demand-driven, patient-centred approach to realize user-friendly, affordable, and scalable AI-driven care technologies.

Reimagine Imaging brings researchers, healthcare providers, and industry together to develop more autonomous MRI and ultrasound technologies that enable faster, better medical diagnoses. By making imaging more accessible throughout the entire care chain, the program reduces pressure on healthcare staff, improves patient care, and helps make healthcare more sustainable.